Trial Profile
A trial of Dolutegravir (DTG) in HIV Infected Treatment Naive Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Mar 2016
Price :
$35
*
At a glance
- Drugs Dolutegravir (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- 01 Mar 2016 New trial record